Navigation Links
Measurements Poor for Assessing Clinical Trials With Children
Date:4/29/2008

Few studies since 1950 had agreement on standard outcomes, review finds

TUESDAY, April 29 (HealthDay News) -- Few studies consider the appropriate measurements for assessing drug clinical trials that enroll children, say University of Liverpool researchers who reviewed 9,000 pediatric clinical trials conducted since 1950.

They also found that few studies have involved parents, and none have involved children in the process to select which measurements to use in assessing clinical trials.

Before they conduct a clinical trial of a new drug, researchers choose several outcomes -- measurements that provide as much information as possible about the drug's safety, effectiveness and impact on the patients' health and daily life, according to background information in the review.

Children's bodies handle drugs very differently than adults' bodies, and it can't be assumed that drugs that work in adults can simply be used in smaller doses to treat children. Pediatric clinical trials need to be designed with these differences in mind.

Of the 9,000 studies, only 25 met the criteria established by the review and examined the selection of outcomes in clinical research in children. The 25 studies came from 13 groups researching a number of conditions, including asthma, cystic fibrosis and Crohn's disease. However, for many conditions that affect children, there has been no work done into the selection of appropriate outcomes for pediatric clinical trials, the review authors said.

They said reaching agreement on standard outcomes for clinical trials in children is important, because it allows comparison and combination of results from different trials. Standardization also helps avoid selectivity and bias in the conduct of research.

The study was published this week in the journal PLoS Medicine.

More information

The U.S. Food and Drug Administration has more about children and clinical trials.



-- Robert Preidt



SOURCE: Public Library of Science, news release, April 28, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Brain measurements could lead to better devices to move injured or artificial limbs
2. Companies Utilize Variety of Metrics for Quality Measurements
3. MedPAC Again Fails to Evaluate Overall Economic Conditions in Assessing SNF Funding Requirements
4. Extremely low dose CT coronary angiography shows promise in assessing cardiac function
5. Radiologists encouraged to look beyond cancer for clinically unseen diseases
6. Clinical depression linked to abnormal emotional brain circuits
7. Preclinical study suggests organ-transplant drug may aid in lupus fight
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Good Clinical Practice Journal Awards: Winners Announced
10. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
11. Study Questions Dead-End Cancer Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: